A hypoechoic liver lesion is an area that looks darker than the surrounding liver on ultrasound. This appearance describes how the area reflects sound waves; it does not identify the cause. Some lesions are harmless, such as focal fatty changes or certain benign growths, while others need closer assessment. The next step depends on the lesion’s size and features, your medical history, and whether further imaging is needed.
Finding a hypoechoic liver lesion on an ultrasound report can raise questions about whether the finding is serious. The term describes how an area looks on an imaging scan rather than providing a specific diagnosis. Many liver lesions are discovered incidentally during scans performed for unrelated reasons. Understanding the report's wording, the appearance of the lesion, and your medical history helps determine whether additional testing is necessary.
What does hypoechoic mean on a liver ultrasound?
Ultrasound uses sound waves to create images of internal organs. Different tissues reflect these waves in different ways, producing lighter or darker areas on the screen. A hypoechoic area reflects fewer sound waves than the surrounding tissue and therefore appears darker.
A hypoechoic liver lesion is a distinct area in the liver that looks darker than the liver tissue around it. The word "lesion" is a general medical term for an abnormal area. It does not automatically mean a tumor or cancer. The appearance may be related to differences in tissue composition, blood flow, or changes in the surrounding liver.
Radiologists interpret this finding by considering other ultrasound features, including the lesion's size, shape, borders, internal appearance, and relationship to nearby structures. The overall appearance of the liver and the clinical information provided with the examination also matter.
What can cause a hypoechoic liver lesion?
Several conditions can produce an area that appears darker than the surrounding liver. Some are benign, while others require more detailed investigation. A hypoechoic appearance alone cannot reliably distinguish between them.
Focal fatty sparing or other localized changes
Fatty liver disease can cause fat to accumulate throughout the liver. In some cases, certain areas contain less fat than the surrounding tissue. These areas, called focal fatty sparing, may appear relatively dark on ultrasound even though they do not represent a separate growth.
A review published in the journal Ultrasound in Medicine & Biology discusses how focal fatty sparing may resemble a liver lesion and why additional contrast-enhanced imaging may be needed when the appearance is not typical. The WFUMB review on incidental liver findings provides further information about evaluating these appearances.
Benign liver growths
Several noncancerous growths can occur in the liver. Their appearance varies according to the type of lesion and the characteristics of the surrounding liver tissue.
- Focal nodular hyperplasia (FNH): A benign growth made of liver cells that develop in an unusual pattern. It is often discovered incidentally and may appear darker than the surrounding liver in certain circumstances.
- Hepatic adenoma: A benign liver tumor that can be associated with hormonal influences and other factors. Its significance depends on its characteristics and clinical context.
- Other benign abnormalities: Some localized tissue changes and benign lesions have appearances that overlap with those of other liver abnormalities, making further characterization necessary.
The NCBI Bookshelf review of focal liver lesions explains how benign lesions, including focal nodular hyperplasia, can have different appearances on ultrasound and other imaging studies. The appearance of a lesion should therefore be interpreted as a whole rather than using the term hypoechoic in isolation.
Potentially serious liver conditions
Some hypoechoic lesions may be associated with liver cancer or cancer that has spread to the liver from another part of the body. Other conditions, including certain inflammatory or infectious abnormalities, may also produce focal changes. These possibilities do not mean that a hypoechoic finding is cancerous; they explain why radiologists sometimes recommend additional testing.
According to Cleveland Clinic's guidance on liver lesions, liver lesions may be benign or malignant, and imaging findings must be evaluated alongside other clinical information. A history of chronic liver disease or previous cancer may influence how a newly discovered lesion is assessed.
Does a hypoechoic liver lesion mean cancer?
No. A hypoechoic liver lesion does not automatically indicate cancer. The term describes an imaging feature, not the biological behavior of the abnormal area. Benign changes can look dark on ultrasound, and some cancerous lesions can also have a similar appearance.
The level of concern depends on the entire imaging picture. A clearly characterized benign lesion in someone without relevant risk factors may need little or no additional evaluation. An indeterminate lesion, however, may require more detailed imaging before its nature can be determined.
Medical history is particularly important. A person with cirrhosis, chronic hepatitis B, or a history of cancer may need a different evaluation from someone without these conditions. Lesion size, changes compared with earlier scans, and other findings in the liver can also influence the next steps.
What happens after a hypoechoic liver lesion is found?
The next step depends on whether the ultrasound provides enough information to identify the lesion confidently. The radiologist may describe a specific likely cause, call the finding indeterminate, or recommend another examination. An indeterminate result means that the available images do not establish the nature of the lesion clearly enough.
Reviewing the ultrasound report
The report may include the lesion's size, location, shape, borders, and other characteristics. It may also describe the liver's overall appearance, whether there are multiple lesions, and whether the scan was limited by image quality. The radiologist's impression and recommendations are particularly useful when discussing the result with a healthcare professional.
Comparing the finding with previous imaging may help establish whether it was already present and whether it has changed. A newly detected lesion is not necessarily a newly developed lesion; earlier scans may simply not have covered the area adequately or may not have shown it clearly.
Additional imaging tests
If the lesion cannot be identified confidently on ultrasound, a healthcare professional may recommend another imaging study. Options can include:
- MRI of the liver: Magnetic resonance imaging can provide detailed information about tissue characteristics and how a lesion behaves after contrast material is given.
- Multiphase CT scan: Computed tomography captures images at different times after contrast material is administered, helping clinicians assess the lesion's blood supply and enhancement pattern.
- Contrast-enhanced ultrasound: Where available and appropriate, this technique uses injected contrast material to help assess blood flow within a liver lesion.
The American College of Radiology's Liver Lesion–Initial Characterization criteria identify contrast-enhanced ultrasound, MRI with and without intravenous contrast, and multiphase contrast-enhanced CT as appropriate options for certain indeterminate liver lesions measuring more than 1 cm on initial ultrasound in people with a normal liver and no evidence of an underlying liver condition or cancer elsewhere. The appropriate test varies with the clinical circumstances and the initial findings.
Blood tests and, occasionally, a biopsy
Blood tests may help assess liver function or investigate a suspected underlying condition. They do not independently establish what a hypoechoic lesion represents. A healthcare professional may consider a biopsy if imaging does not provide a sufficiently clear answer and tissue examination is needed to guide decisions. A biopsy is not automatically required whenever a liver lesion is found.
When is follow-up imaging needed?
Some lesions have imaging features that are sufficiently characteristic of a benign condition that no further testing is necessary. Others require follow-up imaging or additional characterization. The timing and type of follow-up depend on the lesion's appearance, the person's medical history, and the clinical reason for the original scan.
People with cirrhosis or other significant risk factors for liver cancer may follow specific surveillance and diagnostic pathways. RadiologyInfo's explanation of LI-RADS liver imaging describes how ultrasound, CT, and MRI findings are evaluated in people at increased risk of hepatocellular carcinoma. These specialized reporting categories are not intended for every person with an incidental liver lesion.
If your report recommends further imaging, arrange the recommended follow-up with the clinician who ordered the examination. If the recommendation is unclear, ask whether the lesion has been characterized as probably benign or whether additional testing is needed to determine what it represents.
What should you ask your healthcare professional?
Discuss the imaging report in the context of your medical history rather than relying on the word hypoechoic alone. Useful questions include whether the lesion has features of a specific benign condition, whether it was present on earlier scans, and whether the radiologist recommends another test or interval follow-up.
Also mention any history of chronic liver disease, hepatitis, or cancer, along with relevant symptoms and previous imaging results. Persistent or worsening abdominal discomfort and new yellowing of the skin or eyes should be brought to medical attention rather than attributed to the ultrasound finding without assessment.
The main point is that a hypoechoic liver lesion is a description of how an area looks on ultrasound. Its significance depends on what the complete examination shows and whether further imaging or clinical evaluation is necessary.